Cargando…
Straight talk with...Tom Inglesby
When letters containing anthrax spores were mailed to several US senators and media offices in September 2001, just one week after the 9/11 attacks, bioterrorism catapulted to the national stage. Political leaders and public health officials, desperate for guidance on this once-theoretical scenario,...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095964/ https://www.ncbi.nlm.nih.gov/pubmed/23744137 http://dx.doi.org/10.1038/nm0613-657 |
_version_ | 1783510722079096832 |
---|---|
collection | PubMed |
description | When letters containing anthrax spores were mailed to several US senators and media offices in September 2001, just one week after the 9/11 attacks, bioterrorism catapulted to the national stage. Political leaders and public health officials, desperate for guidance on this once-theoretical scenario, turned to experts including Tom Inglesby, then deputy director of the Johns Hopkins Center for Civilian Biodefense Strategies, a bioterrorism research and analysis think tank in Baltimore. In the years that followed, Inglesby and his colleagues ran exercises to simulate bioterror incidents, established a peer-reviewed journal on biodefense and advised government agencies on how to reduce the public health impact of biological threats. Today, he continues his work with the think tank, which moved to the University of Pittsburgh Medical Center (UPMC) in 2003 (although it stayed headquartered in Baltimore) and which was recently renamed the UPMC Center for Health Security. As director and chief executive officer for the past four years, Inglesby has expanded the center's focus toward preventing public health crises arising from infectious diseases, pandemics and major natural disasters, in addition to biological, chemical and nuclear accidents or threats. Inglesby spoke with Kevin Jiang about how responses to bioterrorism, pandemics and natural disasters aren't all that different. |
format | Online Article Text |
id | pubmed-7095964 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Nature Publishing Group US |
record_format | MEDLINE/PubMed |
spelling | pubmed-70959642020-03-26 Straight talk with...Tom Inglesby Nat Med Article When letters containing anthrax spores were mailed to several US senators and media offices in September 2001, just one week after the 9/11 attacks, bioterrorism catapulted to the national stage. Political leaders and public health officials, desperate for guidance on this once-theoretical scenario, turned to experts including Tom Inglesby, then deputy director of the Johns Hopkins Center for Civilian Biodefense Strategies, a bioterrorism research and analysis think tank in Baltimore. In the years that followed, Inglesby and his colleagues ran exercises to simulate bioterror incidents, established a peer-reviewed journal on biodefense and advised government agencies on how to reduce the public health impact of biological threats. Today, he continues his work with the think tank, which moved to the University of Pittsburgh Medical Center (UPMC) in 2003 (although it stayed headquartered in Baltimore) and which was recently renamed the UPMC Center for Health Security. As director and chief executive officer for the past four years, Inglesby has expanded the center's focus toward preventing public health crises arising from infectious diseases, pandemics and major natural disasters, in addition to biological, chemical and nuclear accidents or threats. Inglesby spoke with Kevin Jiang about how responses to bioterrorism, pandemics and natural disasters aren't all that different. Nature Publishing Group US 2013-06-06 2013 /pmc/articles/PMC7095964/ /pubmed/23744137 http://dx.doi.org/10.1038/nm0613-657 Text en © Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. 2013 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Straight talk with...Tom Inglesby |
title | Straight talk with...Tom Inglesby |
title_full | Straight talk with...Tom Inglesby |
title_fullStr | Straight talk with...Tom Inglesby |
title_full_unstemmed | Straight talk with...Tom Inglesby |
title_short | Straight talk with...Tom Inglesby |
title_sort | straight talk with...tom inglesby |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095964/ https://www.ncbi.nlm.nih.gov/pubmed/23744137 http://dx.doi.org/10.1038/nm0613-657 |